Olaparib combined with chemotherapy for recurrent platinum. A comparison of platinumbased and nonplatinumbased. Platinumbased chemotherapy the institute of cancer. Due to the increasing incidence and high mortality associated with colorectal cancer crc, novel therapeutic strategies are urgently needed. Researchers have now identified a way to enhance the in vitro.
Ovarian cancer stem cell like side populations are enriched following chemotherapy and overexpress ezh2. Polymeric micelles for targeted tumor therapy of platinum. Platinumbased drugs have become a mainstay of cancer therapy. Analysis of 17 trials that included 4,920 nsclc patients indicated that the platinumbased treatments are associated with a higher risk of anemia, nausea, and neurotoxicity p 0. Platinum compounds currently used are cisplatin, carboplatin and oxaliplatin, either used alone or in. Pdf the side effects of platinumbased chemotherapy drugs. Understanding and improving platinum anticancer drugs ncbi. Platinumbased anticancer drugs used in the clinic download table. Olaparib maintenance therapy in patients with platinum. The platinumbased drugs in cancer therapy appears to be a comprehensive book useful for scientist, medical oncologist and pharmacist seeking answer on specific questions concerning preclinical and clinical data of platinum drugs.
Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Platinum based agents with respect to their structure, mechanism of action and strategies developed for improved efficacy in cancer treatment have been summarized in this paper with the perspective of developing new platinum drugs or platinum based therapy for individualized cancer treatment. Platinumbased chemotherapeutics represent a mainstay of cancer therapy, but resistance limits their curative potential. They work by by slowing down the growth of cancer cells and killing them. The platinumbased drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, doselimiting side effects also referred to as adverse effectsevents. Timely and interdisciplinary, platinumbased drugs in cancer therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs.
Overcoming resistance to platinumbased drugs in ovarian. Platinum based cancer treatment linkedin slideshare. The resurgence of platinumbased cancer chemotherapy. Ovarian cancer is difficult to treat, largely because tumours are often found late and develop resistance to initial treatment. Platinum chemotherapy for brca1 related breast cancer. A new era of metalbased drugs started in the 1960s, heralded by the discovery of potent platinumbased complexes, commencing with cisplatin h. It is now 20 years since the publication of the antitumour activity of platinum compounds by barnett rosenberg and his colleagues.
Brca12related serous ovarian cancers are highly sensitive to platinum chemotherapy, and remain sensitive to repeat challenges with platinum chemotherapy, which likely. Common drug classes used to treat colon cancer are egfr antagonists, folate analogues, kinase inhibitors, nucleoside metabolic inhibitors, platinumbased drugs, and vegf antibodies. The platinum compounds currently used in nsclc are cisplatin and carboplatin. Platinumbased agents are important drugs or drug candidates for cancer chemotherapy. Resistance to platinumbased chemotherapy is a major clinical problem giaccone, 2000. In total, a cancer patient can experience any combin 2018 frontier and perspective articles. Platinumbased drugs in cancer therapy cancer drug discovery and development. Thus, targeting hctr1 upregulation is an attractive strategy for. This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision. Among the widely used anticancer drugs, the platinum compounds cisplatin and oxaliplatin are most commonly associated with various forms of neurotoxicity.
Clearly, the use of platinum drugs is essential in the fight against cancer. Platinum anticancer agents johnson matthey technology. Different treatments have been applied to kill cancer cells such as chemotherapy, which is the use of chemicals or drugs in order to treat cancer cells. Platinum ptbased antitumor agents remain important chemotherapeutic agents for treating many human malignancies. Used for many of the same cancers and in similar regimens to cisplatin. However, platinumbased chemotherapy regimens did increase complete response rates, at the cost of higher adverse events including nausea and vomiting, anaemia and thrombocytopenia toxicity. Pdf the platinumbased drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective. Traditional platinum drugs including the globally approved cisplatin. This article summarises the history of platinum agents in this field and indicates the current and possible future directions of. Platinum compounds produce changes in dna structure, which causes cancer cell death apoptosis. Neoplasma the strength of the text lies in the diversity of topics that are covered in such a succinct fashion.
Through a kinome rnai screen, we identified microtubuleassociated serinethreonine kinase 1 mast1 as a main driver of cisplatin resistance in human cancers. Each drug is listed once at present, though it might fall in more than one subsection. Although sal analogs showed less promising ic50 values than sal, they were identified as the antitumor agents that significantly overcome the resistance to platinumbased drugs in ovarian cancer, more potent than unmodified sal and commonly used anticancer drugs5fluorouracil, gemcitabine, and cisplatin. Platinum anticancer drugs are effective against a wide range of tumors, though their severe adverse effects and resistance remain unresolved. Biological evaluation of phresponsive polymercaged nanobins for breast cancer therapy, acs nano, 10. Platinum compounds are widely used in the treatment of numerous tumor types, such as ovarian, lung, testicular, and bladder cancer. Mechanism evidencebased clinical decision support at. Costutility analysis of platinumbased chemotherapy. Timely and interdisciplinary, platinum based drugs in cancer therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs. Targeting drug transport mechanisms for improving platinum.
Platinum compounds an overview sciencedirect topics. Platinumbased agents for individualized cancer treatment. During this time platinumbased drugs have made a major contribution to cancer therapy with significant benefits for many patients. In addition, tumor resistance to oxaliplatin is related to. Western michigan university, 2015 cancer is considered the second leading cause of death after heart attack. Platinumbased chemotherapy remains the standardofcare for most patients affected by advanced nonsmall cell lung cancer nsclc. In ovarian cancer approximately 50 percent of tumors are intrinsically resistant to. Almost half of the chemotherapy regimens used today. The side effects of platinumbased chemotherapy drugs. Why is platinum in some chemotherapy drugs, and can we. Overview platinum based therapy refers to a specific class chemotherapy drugs that are derived from the element platinum. Treatment of t24 bladder cancer cells with aqueous cddp loaded into.
Download table platinumbased anticancer drugs used in the clinic from. Platinum based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Elevated expression of the human highaffinity copper transporter 1 hctr1, resulting in enhanced pt drug transport into cells, has been shown to be associated with improved treatment efficacy. However, their applicability and efficacy are limited by drug resistance and adverse effects.
Clendeninn and krzyszt of and current strategies and edited andrew d. Roughly 10 to 20 percent of all cancer patients get a prescription for a platinumbased drug, according to the national cancer institute. Platinumbased chemotherapy regimens did not offer a statistically significant benefit in survival or overall tumour response compared with nonplatinumbased regimens. Despite the pervasiveness of platinum drugs in cancer. The widespread use of platinum agents in the treatment of cancer began with the discovery of the antineoplastic activity of cisplatin by barnett rosenberg in the 1960s. For use in combination with radiation therapy rt for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck scchn or as a single agent for the treatment of patients with recurrent or metastatic scchn for whom prior platinumbased therapy has failed. Cisplatin was first used for cancer therapy in the 1970s. Platinumbased drugs are used to treat ovarian cancer, testicular cancer, and colon cancer. There are three major platinum based cancer treatment drugs these drugs are used to treat advanced forms of a variety of cancers including colon, lung, ovarian, head and neck cancers. Although the data for brca12related breast are therefore relatively limited, there are substantial data on the sensitivity of brca1related and brca2related ovarian cancers to platinumbased chemotherapy 7, 8. Eloxatin, 1r,2rcyclohexane1,2diamineethanedioatoo,oplatinumii formula. Cisplatin, the oldest, has been approved as a cancer treatment since 1978. Understanding and improving platinum anticancer drugs.
Platinumbased drugs in cancer therapy springerlink. Platinumbased cancer drugs destroy tumor cells by binding to dna strands. Soprano and platinumbased drugs in cancer and chemoradiation in cancer therapy and nicholas p. Synthesis of new platinumbased anticancer drugs yasser saud. We recently reported chemotherapy effectiveness results from a national study of 12,181 patients aged 65 years and older diagnosed with stages i to iv ovarian. This channel is dedicated to students of chemistry, medicine, pharmacy, biology, physics, agriculture and other branches studying chemistry. Why certain ovarian cancers develop resistance to platinum. In this randomised, openlabel, phase 2 study, adult patients with platinumsensitive, recurrent, highgrade serous ovarian cancer who had received up to three previous courses of platinumbased chemotherapy and who were progression free for at least 6 months before randomisation received either olaparib 200 mg capsules twice daily, administered orally on days 110 of each 21day cycle. Enhancing the effects of platinumbased anticancer drugs. The most widely used anticancer drugs are platinumbased. The emergent platinum drugs of the futureorally active agents, the sterically hindered zd0473, and the polynuclear charged platinum bbr3464are also fully considered. Platinum complexes as anticancer agents recent patents on anticancer drug discovery, 2006, vol. Trans platinum complexes in cancer therapy anti cancer agents in medicinal chemistry, 2007, vol.
Platinum and taxane combination is the recommended primary therapy for cancer stages ic to iv, while single agents may be administered depending on the platinum sensitivity of the tumor. Their clinical success is, however, limited due to severe side effects and intrinsic. However, the toxic side effects must be attenuated to reap the maximum benefits. Enhancing the effects of platinumbased anticancer drugs date. Timely and interdisciplinary, platinumbased drugs in cancer therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from. Why certain ovarian cancers develop resistance to platinumbased chemotherapy. Classic chemotherapy against crc is based on oxaliplatin and other cisplatin analogues.
Interest in platinum drugs has been revived recently. Doctors use platinum drugs to treat many kinds of cancer, both alone and in combination with other drugs. Platinum therapy is the use of platinum compounds, which are cell damaging agents, for the treatment of specific cancers, including testicular, ovarian, lung, bladder, and head and neck cancers. Much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clinical application so far. Platinumbased drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Indeed, 36 of 75 anticancer treatment regimens listed in martindale drug reference book are platinumbased, while pt drugs are prescribed. Platinumbased chemotherapy in advanced nonsmallcell. Platinumbased chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer, however acquired drug resistance is a major clinical obstacle. Treatment for colon cancer includes surgery, chemotherapy, and radiation therapy. Drug combination may be highly effective in recurrent.
Screeningbased approach to discover effective platinumbased. The incidence, clinical manifestations, possible mechanisms of neurotoxicity, and management of neurotoxicities other than peripheral neuropathy with cisplatin, oxaliplatin, and the less. Platinumbased agents with respect to their structure, mechanism of action and strategies developed for improved efficacy in cancer treatment have been summarized in this paper with the perspective of developing new platinum drugs or platinumbased therapy for individualized cancer treatment. The availability of new generation drugs has led to the adoption of schedules with lower doses of platinum compounds leading to. Platinum neurotoxicity pharmacogenetics molecular cancer. The clinical toxicology of the platinum drugs is a subject area concerned with the adverse effects caused by platinumbased cancer chemotherapeutic agents in patients at doses conventionally used in cancer therapy. Fulltext platinumbased anticancer drugs encapsulated liposome.
151 784 1182 667 250 163 519 706 1630 1387 304 1184 813 1237 610 983 1497 538 944 473 897 359 622 934 1247 464 436 970 573 837 1033 1188 60 1404 465 1342 112 591 963 192 1261